The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease

NCT04613466 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-11-13

No results posted yet for this study

Summary

Bronchopulmonary manifestations signs and symptoms are variable extraintestinal manifestations of IBD.

Conditions

  • The Prevelance and Complications of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-12-01
Completion
2022-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04613466 on ClinicalTrials.gov